Optometrists Can Now Treat Glaucoma In Massachusetts
Optometrists Can Now Treat Glaucoma In Massachusetts Read More »
Regardless of whether you’re a first or a fourth-year optometry student, glaucoma is something we all must become familiar with for our profession. Though most optometry students spend a significant amount of time learning about the glaucoma, it’s a topic worth revisiting regularly, which is why we’ve got a quick guide that you can easily
Navigating Glaucoma for Optometry Students Read More »
Glaukos Corp. has received FDA approval for its iStent Trabecular Micro-Bypass, This is the first glaucoma implant to be approved in the United States (U.S.). The iStent is indicated for use in conjunction with cataract surgery for the reduction of IOP in adult patients with mild to moderate open-angle glaucoma currently treated with ocular
FDA approves first micro-device for glaucoma treatment Read More »
The new product named “Triggerfish” is a contact lens adapted with a sensor that provides IOP measurements for a full 24 hours. Â The current study involved 19 patients with confirmed glaucoma and 21 suspected of having the condition. Â Each patient wore the adapted contact lens sensor on one eye for 24 hours in each of
New Sensor-adapted Contact Lens is Promising for the Study of Glaucoma Read More »
There are so many different medications used to treat Glaucoma it is often difficult to know which drugs to use first and which drugs to use if the first drug you pick doesn’t lower the patient’s IOP enough. So here are some clinical pearls to help you manage Glaucoma patients: First, define your target pressure. This is the IOP that
The ABCs of Treating Glaucoma Medically Read More »
By: Antonio Chirumbolo SUNY 2013 February 15th 2013- The FDA has approved Zioptan (Tafluprost), a preservative free prostaglandin analog, for the treatment of certain kinds of glaucoma. The ophthalmic solution reduces IOP in patients with open angle glaucoma and ocular hypertension. Results from five controlled clinical studies helped spur the approval of the drug, showing
Tafluprost – FDA Approved to Treat Glaucoma Read More »
January 7th 2012-Â Glaucoma, right behind cataracts is the second leading cause of blindness in the world. January marks National Glaucoma Awareness Month. Some of the biggest groups and organizations in eyecare are educating the public about this blinding disease and to get comprehensive eye exams such as the American Optometric Association, Prevent Blindness America, the
National Glaucoma Awareness Month Read More »
Today we have an urgent news post from NECO Students– Jeff Cohn, Mirage Shah and the OD’s of Massachusetts. We want to encourage all Optometry Students to do a great thing for the profession of optometry- help to get a bill passed that will allow OD’s to treat Glaucoma in the state of Massachusetts. By
Massachusetts Glaucoma Bill Read More »
Embarking on my optometry school journey amid the unprecedented times of the COVID-19 pandemic has been a unique and challenging experience, emphasizing the importance of adaptability in an ever-changing world. In this era dominated by technology, the shift to virtual learning became a cornerstone for education, requiring students to embrace change and find innovative ways
The Evolving Role of AI and Optometry Read More »
Registration is now open for AOA on Capitol Hill, April 14-16, in Washington, D.C. Hope to see you there! AOA on Capitol Hill is the AOA’s single-largest annual advocacy event, directly connecting optometry’s advocates and leaders with our nation’s policymakers to advance and support optometric care in America. Lawmakers love hearing from optometry students because
Take Action: Why You Should Attend AOA on Capitol Hill 2024 Read More »